Harrow Retained Earnings Total Equity from 2010 to 2024

HROWL Stock  USD 25.33  0.03  0.12%   
Harrow Health Retained Earnings Total Equity yearly trend continues to be quite stable with very little volatility. The value of Retained Earnings Total Equity is projected to decrease to about -103.5 M. Retained Earnings Total Equity is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. View All Fundamentals
 
Retained Earnings Total Equity  
First Reported
2010-12-31
Previous Quarter
-98.5 M
Current Value
-103.5 M
Quarterly Volatility
11.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as Interest Expense of 22.4 M, Selling General Administrative of 70.3 M or Selling And Marketing Expenses of 5.2 M, as well as many indicators such as Price To Sales Ratio of 2.67, Dividend Yield of 6.0E-4 or PTB Ratio of 4.9. Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.
  
Check out the analysis of Harrow Health Correlation against competitors.
For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

Latest Harrow Health's Retained Earnings Total Equity Growth Pattern

Below is the plot of the Retained Earnings Total Equity of Harrow Health 8625 over the last few years. It is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. Harrow Health's Retained Earnings Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harrow Health's overall financial position and show how it may be relating to other accounts over time.
Retained Earnings Total Equity10 Years Trend
Slightly volatile
   Retained Earnings Total Equity   
       Timeline  

Harrow Retained Earnings Total Equity Regression Statistics

Arithmetic Mean(83,887,639)
Coefficient Of Variation(13.70)
Mean Deviation9,515,204
Median(77,400,000)
Standard Deviation11,494,153
Sample Variance132.1T
Range32.1M
R-Value(0.75)
Mean Square Error61.6T
R-Squared0.57
Significance0
Slope(1,935,184)
Total Sum of Squares1849.6T

Harrow Retained Earnings Total Equity History

2024-103.5 M
2023-98.5 M
2022-109.5 M
2021-95.4 M

About Harrow Health Financial Statements

Harrow Health investors utilize fundamental indicators, such as Retained Earnings Total Equity, to predict how Harrow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Retained Earnings Total Equity-98.5 M-103.5 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Harrow Health 8625 is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:
Check out the analysis of Harrow Health Correlation against competitors.
For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity
0.4484
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.